Mark Roffman
Vorstandsvorsitzender bei Clinsearch, Inc.
Profil
Mark Roffman is Head of Clinical Development for Gel Med Sciences, Inc. and President and Chief Executive Officer of ClinSearch, Inc. Prior to joining Gel Med Sciences, he was Vice President of Clinical and Regulatory Affairs for Agile Therapeutics, Inc. Previously, Dr. Roffman held senior positions at Novartis, Inc. and SmithKline Beecham.
He has more than 20 years of experience in drug development.
Aktive Positionen von Mark Roffman
| Unternehmen | Position | Beginn |
|---|---|---|
Gel Med Sciences, Inc.
 Gel Med Sciences, Inc. Pharmaceuticals: MajorHealth Technology Gel Med Sciences, Inc. engages in the development of animal and human healthcare products. It offers ovugel that utilizes the company's gel drug delivery system to improve the timing of artificial inseminations in pig herds. The company was founded by Joseph S Duffey in 1999 and is headquartered in Wayne, PA. | Corporate Officer/Principal | - |
Clinsearch, Inc.
 Clinsearch, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Comprehensive Clinical Development, Inc., Clinsearch, Inc. provides clinical research services. The company is based in Kenilworth, NJ. The CEO of the company is Mark Roffman. Clinsearch was acquired by Comprehensive NeuroScience, Inc. on July 29, 2002. | Vorstandsvorsitzender | 14.05.2009 |
Ehemalige bekannte Positionen von Mark Roffman
| Unternehmen | Position | Ende |
|---|---|---|
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Corporate Officer/Principal | - |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Corporate Officer/Principal | - |
| AGILE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AGILE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Health Technology |
Gel Med Sciences, Inc.
Gel Med Sciences, Inc. Pharmaceuticals: MajorHealth Technology Gel Med Sciences, Inc. engages in the development of animal and human healthcare products. It offers ovugel that utilizes the company's gel drug delivery system to improve the timing of artificial inseminations in pig herds. The company was founded by Joseph S Duffey in 1999 and is headquartered in Wayne, PA. | Health Technology |
Clinsearch, Inc.
Clinsearch, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Comprehensive Clinical Development, Inc., Clinsearch, Inc. provides clinical research services. The company is based in Kenilworth, NJ. The CEO of the company is Mark Roffman. Clinsearch was acquired by Comprehensive NeuroScience, Inc. on July 29, 2002. | Commercial Services |
